ESC Premium Access

Low dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndrome (LILACS)

Congress Session

About the speaker

Doctor Tian Zhao

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)
0 follower

5 more presentations in this session

Low-density lipoprotein cholesterol <50 mg/dL is an appropriate target after acute coronary syndrome: propensity score-matched analysis of the ODYSSEY OUTCOMES trial

Speaker: Professor G. Schwartz (Aurora, US)

Thumbnail

Onyx ONE: Outcomes in patients with acute coronary syndrome

Speaker: Doctor E. Kedhi (Brugge, BE)

Thumbnail

Differences in revascularization strategy and outcomes in ST-elevation and non-ST-elevation myocardial infarction with spontaneous coronary artery dissection

Speaker: Doctor T. Inohara (Tokyo, JP)

Thumbnail

Prasugrel compared to ticagrelor in primary PCI

Speaker: Doctor J. Doerler (Innsbruck, AT)

Thumbnail

Sex disparities in completeness of revascularisation and outcomes in patients with ST-elevation myocardial infarction and multivessel coronary artery disease.

Speaker: Doctor N. Mahdi (Calgary, CA)

Thumbnail

Access the full session

Advances in Treatment of Acute Coronary Syndrome

Speakers: Doctor T. Zhao, Professor G. Schwartz, Doctor E. Kedhi, Doctor T. Inohara, Doctor J. Doerler...
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

This platform is supported by

logo Novo Nordisk